Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T17:59:09.428Z Has data issue: false hasContentIssue false

Adjunctive Therapy in Depression: A Controlled Trial of Nialamide

Published online by Cambridge University Press:  08 February 2018

J. W. Affleck
Affiliation:
The Royal Edinburgh Hospital, Morningside
A. D. Forrest
Affiliation:
The Royal Edinburgh Hospital, Morningside
F. M. Martin
Affiliation:
Department of Social Medicine, University of Edinburgh
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The efficacy of anti-depressant drugs, including imipramine and the so-called monoaminase inhibitors, and their potential as a replacement for E.C.T. remain undefined. Imipramine, which has been most extensively studied, has been shown to produce an initially lower improvement rate than E.C.T. in depressives, though after six months the results are little different (Kiloh and Ball, 1961). Dewhurst and Pare (1961) have reported that the quality of improvement in the cases who improved with nialamide in their partially blind trial was comparable to that seen with electroplexy. There is still a lack of controlled trials on the monoaminase inhibitors, particularly as regards patients sufficiently disturbed to warrant hospitalization. Harris and Robin (1960) found no evidence that phenelzine influenced recovery in these patients.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1961 
Submit a response

eLetters

No eLetters have been published for this article.